Dr. Robin Jones on Olaratumab and Doxorubicin in Patients with Soft Tissue Sarcoma
3 Visualizzazioni
• 07/18/23
0
0
Incorporare
administrator
Iscritti
Robin Jones, BSc, MB, MRCP, MD, oncologist, Royal Marsden Hospital, London, discusses the effectiveness of monoclonal antibody olaratumab in combination with doxorubicin in unresectable and metastatic soft tissue sarcoma.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti